万春药业(BYSI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BYSI 万春药业

盘前交易 10-12 05:57:45 EDT

0.6056

-0.0034

-0.56%

最高0.6698	最低0.5900	成交量5.88万
今开0.5900	昨收0.6090	日振幅13.10%
总市值2,490万	流通市值1,935万	总股本4,112万
成交额3.62万	换手率0.18%	流通股本3,195万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BYSI","market":"US","secType":"STK","nameCN":"万春药业","latestPrice":0.6056,"timestamp":1791576000000,"preClose":0.609,"halted":0,"volume":58780,"delay":0,"changeRate":-0.005582922824302066,"floatShares":31950100,"shares":41122299,"eps":-0.163815,"marketStatus":"盘前交易","change":-0.0034,"latestTime":"10-12 05:57:45 EDT","open":0.59,"high":0.6698,"low":0.59,"amount":36174.5792228,"amplitude":0.131034,"askPrice":0.669,"askSize":1057,"bidPrice":0.585,"bidSize":950,"shortable":3,"etf":0,"ttmEps":-0.163815,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791811800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1489035600000,"exchange":"NASDAQ","adjPreClose":0.6056,"postHourTrading":{"tag":"盘后","latestPrice":0.669,"preClose":0.6056,"latestTime":"19:58 EDT","volume":1253,"amount":830.736,"timestamp":1791590338790,"change":0.0634,"changeRate":0.10469,"amplitude":0.10469},"volumeRatio":0.6539355326374512,"impliedVol":0.4474,"impliedVolPercentile":0.968},"requestUrl":"/m/hq/s/BYSI/tweets","defaultTab":"tweets","newsList":[{"id":"1141481854","title":"万春药业宣布领导层更迭，旨在集中推进确认性Dublin-4项目并创造长期价值","url":"https://stock-news.laohu8.com/highlight/detail?id=1141481854","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141481854?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:07","pubTimestamp":1780571221,"startTime":"0","endTime":"0","summary":"万春药业宣布进行领导层调整，以集中资源推进其确认性Dublin-4项目的执行，并致力于实现公司的长期价值创造。这一战略举措旨在优化运营效率，确保核心研发管线获得专注的推动力。公司期待通过强化领导结构，加速关键临床项目的进展，从而为未来发展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103128765","title":"万春药业：黄岚留任董事长，专注执行种子治疗业务","url":"https://stock-news.laohu8.com/highlight/detail?id=1103128765","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103128765?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:03","pubTimestamp":1780571003,"startTime":"0","endTime":"0","summary":"万春药业宣布，黄岚将继续担任公司董事长一职，同时将执行职责聚焦于种子治疗业务领域。这一调整旨在强化公司在该核心业务板块的战略布局与运营管理。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514905810","title":"万春医药盘中异动 大幅跳水6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514905810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514905810?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493907,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，万春医药股票出现波动，股价急速下跌6.15%。截至发稿，该股报1.68美元/股，成交量806股，换手率0.00%，振幅0.00%。万春医药股票所在的生物技术行业中，整体涨幅为0.36%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223147a25386be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223147a25386be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514302779","title":"万春医药盘中异动 大幅跳水5.03%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514302779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514302779?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:55","pubTimestamp":1740416147,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时55分，万春医药股票出现波动，股价大幅下跌5.03%。截至发稿，该股报1.70美元/股，成交量3566股，换手率0.01%，振幅4.47%。万春医药股票所在的生物技术行业中，整体涨幅为0.00%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225005547962eb8d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225005547962eb8d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166467","title":"万春医药盘中异动 股价大涨5.26%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512166467?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:46","pubTimestamp":1739889990,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时46分，万春医药股票出现波动，股价快速上涨5.26%。截至发稿，该股报1.80美元/股，成交量7035股，换手率0.02%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.88%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224630a24ab033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224630a24ab033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510354596","title":"万春医药盘中异动 临近收盘股价大跌5.66%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510354596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510354596?lang=zh_cn&edition=full","pubTime":"2025-02-12 04:39","pubTimestamp":1739306355,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日04时39分，万春医药股票出现异动，股价快速下挫5.66%。截至发稿，该股报1.63美元/股，成交量1.8305万股，换手率0.05%，振幅2.60%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为2.01%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212043915a242483d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212043915a242483d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","OCEA","OMGA","BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509320088","title":"万春医药盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509320088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509320088?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:34","pubTimestamp":1738866862,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日02时34分，万春医药股票出现波动，股价急速下挫5.31%。截至发稿，该股报1.70美元/股，成交量3914股，换手率0.01%，振幅4.56%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为0.18%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207023422987cb19a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207023422987cb19a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508457633","title":"万春医药盘中异动 快速上涨5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508457633?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:37","pubTimestamp":1738679830,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时37分，万春医药股票出现异动，股价急速上涨5.84%。截至发稿，该股报1.79美元/股，成交量7股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.10%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223711a2392a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223711a2392a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508142702","title":"万春医药盘中异动 股价大跌5.59%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508142702?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:19","pubTimestamp":1738595949,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时19分，万春医药股票出现异动，股价大幅跳水5.59%。截至发稿，该股报1.69美元/股，成交量5845股，换手率0.01%，振幅2.23%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为1.15%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231909961703ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231909961703ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506512595","title":"万春医药盘中异动 早盘股价大涨6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506512595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506512595?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:35","pubTimestamp":1738074904,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时35分，万春医药股票出现波动，股价急速上涨6.51%。截至发稿，该股报1.80美元/股，成交量1.283万股，换手率0.03%，振幅2.37%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.04%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223505a2326fc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223505a2326fc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505877683","title":"万春医药盘中异动 股价大跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505877683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505877683?lang=zh_cn&edition=full","pubTime":"2025-01-23 01:17","pubTimestamp":1737566232,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日01时17分，万春医药股票出现波动，股价大幅下挫5.62%。截至发稿，该股报1.66美元/股，成交量3.5119万股，换手率0.09%，振幅2.56%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为0.06%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123011712a22bd48a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123011712a22bd48a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503677967","title":"万春医药盘中异动 大幅拉升6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503677967","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503677967?lang=zh_cn&edition=full","pubTime":"2025-01-16 05:00","pubTimestamp":1736974851,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日05时00分，万春医药股票出现异动，股价大幅拉升6.06%。截至发稿，该股报1.75美元/股，成交量8605股，换手率0.02%，振幅4.85%。万春医药股票所在的生物技术行业中，整体涨幅为1.27%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011605005196050618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011605005196050618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502189971","title":"万春医药盘中异动 股价大涨5.21%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502189971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502189971?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:15","pubTimestamp":1736525741,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时15分，万春医药股票出现异动，股价急速拉升5.21%。截至发稿，该股报1.72美元/股，成交量2540股，换手率0.01%，振幅2.46%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为1.63%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111001541aba61b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111001541aba61b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502777373","title":"万春医药盘中异动 早盘大幅下挫6.40%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502777373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502777373?lang=zh_cn&edition=full","pubTime":"2025-01-09 00:13","pubTimestamp":1736352811,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日00时13分，万春医药股票出现异动，股价急速下跌6.40%。截至发稿，该股报1.61美元/股，成交量2323股，换手率0.01%，振幅5.23%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.27%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109001331985f8b51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109001331985f8b51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139","SANA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501521452","title":"万春医药盘中异动 临近午盘股价大涨6.75%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501521452","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501521452?lang=zh_cn&edition=full","pubTime":"2025-01-07 00:32","pubTimestamp":1736181132,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日00时32分，万春医药股票出现波动，股价大幅拉升6.75%。截至发稿，该股报1.74美元/股，成交量4214股，换手率0.01%，振幅5.52%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.53%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。该公司还专注于包括免疫肿瘤药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107003212a217b124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107003212a217b124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","OCEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500211783","title":"万春医药盘中异动 股价大涨8.81%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500211783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500211783?lang=zh_cn&edition=full","pubTime":"2025-01-03 23:05","pubTimestamp":1735916703,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日23时05分，万春医药股票出现异动，股价急速上涨8.81%。截至发稿，该股报1.73美元/股，成交量858股，换手率0.00%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体涨幅为0.34%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103230503a2147031&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103230503a2147031&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494386604","title":"万春医药盘中异动 大幅上涨5.72%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494386604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494386604?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:33","pubTimestamp":1735309986,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时33分，万春医药股票出现波动，股价大幅上涨5.72%。截至发稿，该股报1.76美元/股，成交量1441股，换手率0.00%，振幅1.82%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为0.41%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122722330695ef74c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122722330695ef74c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493038760","title":"万春医药盘中异动 早盘股价大跌6.17%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493038760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493038760?lang=zh_cn&edition=full","pubTime":"2024-12-24 23:30","pubTimestamp":1735054204,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日23时30分，万春医药股票出现异动，股价大幅下挫6.17%。截至发稿，该股报1.64美元/股，成交量2289股，换手率0.01%，振幅1.71%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为0.16%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224233005a207ce44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224233005a207ce44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493766123","title":"万春医药盘中异动 早盘急速上涨5.03%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493766123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493766123?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:33","pubTimestamp":1734964392,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时33分，万春医药股票出现波动，股价大幅上涨5.03%。截至发稿，该股报1.67美元/股，成交量1494股，换手率0.00%，振幅0.63%。万春医药股票所在的生物技术行业中，整体涨幅为0.06%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223313984d3b24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223313984d3b24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492214174","title":"万春医药盘中异动 早盘股价大涨6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492214174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492214174?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:49","pubTimestamp":1734619793,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时49分，万春医药股票出现波动，股价急速拉升6.54%。截至发稿，该股报1.63美元/股，成交量1384股，换手率0.00%，振幅1.38%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。万春医药股票所在的生物技术行业中，整体跌幅为3.47%。万春医药公司简介：BeyondSpring Inc 从事临床阶段的生物制药活动，重点是开发癌症疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224953984cd9c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219224953984cd9c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beyondspringpharma.com","stockEarnings":[{"period":"1week","weight":-0.2308},{"period":"1month","weight":-0.0367},{"period":"3month","weight":-0.5794},{"period":"6month","weight":-0.652},{"period":"1year","weight":-0.6654},{"period":"ytd","weight":-0.6285}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.0313},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1417}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"万春医药公司于2014年11月21日在开曼群岛注册成立。该公司是一家处于全球临床阶段的生物制药公司,专注于新型癌症疗法，包括晚期肿瘤免疫药物的研发。在万春医药，其使命是利用他们的癌症治疗的学术及业务能力，采用独有方式来改变癌症治疗的现状。公司成立于2013年，总部设立在美国。他们的主要项目普那布林来源于天然化合物，由于所具有的各种生化活性，对多种癌症有治疗潜力。他们采用一种新颖的、高度可扩展的商业模式，整合美中优势资源，高效、低成本地实现药物的报批和开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.015905},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.057049},{"month":3,"riseRate":0.333333,"avgChangeRate":0.116955},{"month":4,"riseRate":0.4,"avgChangeRate":-0.026397},{"month":5,"riseRate":0.7,"avgChangeRate":0.088397},{"month":6,"riseRate":0.7,"avgChangeRate":0.107409},{"month":7,"riseRate":0,"avgChangeRate":-0.154153},{"month":8,"riseRate":0.4,"avgChangeRate":0.157233},{"month":9,"riseRate":0.6,"avgChangeRate":-0.032191},{"month":10,"riseRate":0.3,"avgChangeRate":-0.081489},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.052314},{"month":12,"riseRate":0.444444,"avgChangeRate":0.140673}],"exchange":"NASDAQ","name":"万春药业","nameEN":"Beyondspring Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万春药业(BYSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万春药业(BYSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万春药业,BYSI,万春药业股票,万春药业股票老虎,万春药业股票老虎国际,万春药业行情,万春药业股票行情,万春药业股价,万春药业股市,万春药业股票价格,万春药业股票交易,万春药业股票购买,万春药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万春药业(BYSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万春药业(BYSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}